Safety of bridging antiplatelet therapy with the gpIIb-IIIa inhibitor tirofiban after emergency stenting in stroke.
In a proportion of stroke patients with acute large vessel occlusion permanent stent implantation is mandatory to achieve successful recanalization. The optimum platelet inhibition strategy after such emergency stenting is unknown. We therefore analyzed the outcome of early glycoprotein (gp) IIb/III...
Main Authors: | John-Ih Lee, Michael Gliem, Gebke Gerdes, Bernd Turowski, Marius Kaschner, Bastian Kraus, Hans-Peter Hartung, Sebastian Jander |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5745002?pdf=render |
Similar Items
-
Comparative assessment of platelet GpIIb/IIIa receptor occupancy ratio with Eptifibatide/Tirofiban in patients presenting with ACS and undergoing PCI
by: Aniket Puri, et al.
Published: (2013-03-01) -
The antiaggregative mechanism of pyridoxal -5''- phosphate (PLP) on the glycoprotein IIb-IIIa( GPIIb-IIIa) and morphology of platelets
by: Wen - Jen Yu, et al.
Published: (1995) -
Study on the antiplatelet aggregation of B6 vitamers by the occupancy of GPIIb/IIIa receptor
by: Chien-Wen Chen, et al.
Published: (2002) -
Kombination von gpIIb/IIIa-Blockade und adoptivem T-Zell-Transfer im Modell der Metastasierung des B16-Melanoms.
by: Chiapponi, Costanza
Published: (2011) -
Antagonistas do receptor plaquetário GPIIb/IIIa
by: M.E.W. Gomes, et al.
Published: (2000-09-01)